|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
价值评估 |
盈利(现时/预测)
-10.30/-0.42
|
企业价值
94.86M
|
资产负债 |
每股账面净值
1.39
|
现金流量 |
现金流量率
--
|
损益表 |
收益
17.98M
|
每股收益
0.69
|
同行比较
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
报价延迟最少15分钟:2024/04/29 04:47 EDT
同行比较之报价最少15分钟延迟
业务概览
|
|||
Celularity Inc is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells, targeting indications across cancer, immunologic, infectious, and degenerative diseases. |